In a critical boost to President Joe Biden’s reelection prospects, the Food and Drug Administration has approved a new Alzheimer’s drug that “may modestly slow the pace of cognitive decline,” according to the New York Times. Biden, the first octogenarian president in American history, is expected to formally announce his plans to seek a second term […]

The post FDA Fast-Tracks New Alzheimer’s Drug in Boost to Biden’s Reelection Bid appeared first on The Black Chronicle.